Zydus Lifesciences Shares Dip 1.36% Amid Heavy Volumes; Strong Financials Reported

• Zydus Lifesciences shares fell 1.36% to 895.20 rupees per share on Friday with heavy trading volumes.
• The company reported a consolidated quarterly revenue of 6,123.20 crore rupees and a net profit of 1,233.40 crore rupees for September 2025.
• Annual revenue for March 2025 reached 23,241.50 crore rupees, with net profit at 4,614.80 crore rupees, showing significant year-on-year growth.
• Key financial ratios for March 2025 include an EPS of 44.97 rupees and a dividend per share of 11.00 rupees.
• Moneycontrol analysis on January 2, 2026, indicated a bearish sentiment for Zydus Lifesciences stock.

Why It Matters: Despite strong financial growth, Zydus Lifesciences shares saw a 1.36% decline on heavy volumes.